Users Coming Off Anti-Obesity Injections Regain Pounds Far More Rapidly Compared to Dieters

Fresh analysis reveals that individuals who stop using blockbuster GLP-1 drugs like semaglutide or tirzepatide tend to recover reduced body mass much more quickly than those who stop conventional diet and exercise regimens.

Published data in a major medical journal points out that while obese people frequently drop substantial amounts of their total mass while on the medication, the mass comes back at an estimated rate of nearly a kilo each month once they quit.

"Users using such medications need to be cognizant of the danger of rapid rebound weight gain when the medication concludes," stated researcher Dr. Susan Jebb.

That rate of recovery suggests a reversion to starting weight in about 18 months.

Analyzing Treatments

The research, which looked at 37 of trials involving thousands of participants, compared the effects of GLP-1 agonists with other pills.

Scientists point out that individuals who shed pounds through diet and exercise typically have a less rapid weight regain—around 0.1 kg a month—after stopping.

Explaining the Fast Regain

Doctors propose the mechanism of the drugs accounts for the accelerated regain.

The injections copy a body's own chemical called glucagon-like peptide-1, which moderates hunger.

"Long-term administration of GLP-1 concentrations far above than normal could lead to the system to generate a reduced amount of its endogenous hormone, and could reduce sensitivity to its actions," noted Dr. Adam Collins, a dietetics expert.

"Withdrawal of this GLP-1 'fix' means appetite is uncontrolled, making binge eating much more probable."

A Lifelong Condition?

The NHS suggest the injections for people with weight-linked medical conditions, alongside prescribed lifestyle changes.

Many experts say that, given the likelihood of relapse, the therapy should be considered ongoing.

This perspective is reinforced by drug manufacturers, who say that the results "highlight the persistent nature of excess weight," comparing it to managing diseases like high blood pressure.

Patient Testimonies

Individuals who have stopped the medication explain a intense resurgence of appetite.

"It was like a trigger activating and I was suddenly extremely hungry," recalled an individual.

The struggle is worsened if users have not established permanent lifestyle or habit modifications during treatment.

Significant Adoption

Recent estimates suggest that a significant number of adults in the UK have tried these injections in the past year, with desire continuing to grow.

• Adoption is more common among women compared to males.
• The 40s and 50s demographic shows the greatest usage rates.
• Many obtain the medications through private healthcare rather than the NHS.

Finally, researchers stress that while the jabs are powerful tools for shedding pounds, they are not a standalone solution and maintained weight loss relies on combined lifestyle changes.